Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Relay Therapeutics (RLAY) Times Interest Earned (2020 - 2023)

Historic Times Interest Earned for Relay Therapeutics (RLAY) over the last 4 years, with Q1 2023 value amounting to -$33725.7.

  • Relay Therapeutics' Times Interest Earned fell 102918.96% to -$33725.7 in Q1 2023 from the same period last year, while for Dec 2023 it was -$124333.3, marking a year-over-year decrease of 77244.17%. This contributed to the annual value of -$91174.5 for FY2021, which is 251451.0% down from last year.
  • As of Q1 2023, Relay Therapeutics' Times Interest Earned stood at -$33725.7, which was down 102918.96% from -$2986.7 recorded in Q1 2022.
  • In the past 5 years, Relay Therapeutics' Times Interest Earned registered a high of $4373.5 during Q4 2020, and its lowest value of -$33725.7 during Q1 2023.
  • Its 4-year average for Times Interest Earned is -$9563.5, with a median of -$7901.2 in 2020.
  • As far as peak fluctuations go, Relay Therapeutics' Times Interest Earned surged by 6478.35% in 2022, and later tumbled by 102918.96% in 2023.
  • Relay Therapeutics' Times Interest Earned (Quarter) stood at $4373.5 in 2020, then tumbled by 293.92% to -$8481.0 in 2021, then surged by 64.78% to -$2986.7 in 2022, then tumbled by 1029.19% to -$33725.7 in 2023.
  • Its last three reported values are -$33725.7 in Q1 2023, -$2986.7 for Q1 2022, and -$8481.0 during Q1 2021.